Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H15Cl2N5O5 |
Molar mass | 440.24 g·mol−1 |
3D model ( JSmol) | |
| |
|
TERN-501 is a selective thyromimetic drug that is being developed for the treatment of non-alcoholic fatty liver disease. [1] [2]
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
PubChem CID | |
ChEMBL | |
Chemical and physical data | |
Formula | C17H15Cl2N5O5 |
Molar mass | 440.24 g·mol−1 |
3D model ( JSmol) | |
| |
|
TERN-501 is a selective thyromimetic drug that is being developed for the treatment of non-alcoholic fatty liver disease. [1] [2]